| |
|
|
|
| |
|
 |
|
|
|
| Nostrum Pharmaceuticals is engaged in the formulation and commercialization of specialty pharmaceutical products and controlled-release, orally-administered, branded and generic drugs. Pharmaceutical companies are increasingly utilizing controlled-release drug delivery technologies to improve therapy. These technologies allow for the development of “patient-friendly” dosage forms, which reduce frequency of drug administration, thus improving patient compliance. Controlled-release pharmaceuticals can be especially beneficial for certain patient populations, such as the elderly, who often require several medications with differing dosing regimens. |
|
| Nostrum Pharmaceuticals has a rich portfolio of approved and filed Intellectual Property. (more) Nostrum’s rich portfolio is supported by research and development in India through its Enem Nostrum facility as well as technology transfer and production at its Nostrum Laboratories, Inc facility in Kansas City, MO. |
| |
|
|
| |
|
 |
|
| |
|
Best Viewed at 1024x768, IE 7.0 |
|
| |
|
© Nostrum Pharmaceuticals LLC. 2008 |
|
|
